The objective of this proposal is to advance medication development for alcohol use disorder by examining the efficacy and mechanisms of action of minocycline, a neuroimmune modulator, as a potential treatment. This study has important clinical implications, as the available treatments for alcohol use disorder are only modestly effective and testing novel medications is a high research priority.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Neuroinflammation
Timeframe: Change from baseline after 28 days of medication dosing
Cue-Induced Alcohol Craving
Timeframe: Change from baseline after 28 days of medication dosing
Alcohol consumption
Timeframe: Change from baseline after 28 days of medication dosing
Verbal Fluency/Language
Timeframe: Change from baseline after 28 days of medication dosing
Speed of processing
Timeframe: Change from baseline after 28 days of medication dosing
Speed of processing
Timeframe: Change from baseline after 28 days of medication dosing
Speed of processing
Timeframe: Change from baseline after 28 days of medication dosing
Working Memory
Timeframe: Change from baseline after 28 days of medication dosing
Attention
Timeframe: Change from baseline after 28 days of medication dosing
Problem Solving/Executive Functioning
Timeframe: Change from baseline after 28 days of medication dosing
Inhibition/Impulsivity
Timeframe: Change from baseline after 28 days of medication dosing
Verbal Learning
Timeframe: Change from baseline after 28 days of medication dosing
Visual Learning
Timeframe: Change from baseline after 28 days of medication dosing